enoxacin

(redirected from Penetrex)

enoxacin

 [ĕ-nok´sah-sin]
an antibacterial effective against many gram-positive and gram-negative bacteria; administered orally in the treatment of gonorrhea and urinary tract infections.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

Bactidron

A fluoroquinolone which is no longer available in the US and many developed nations.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.

enoxacin

Antibiotics A broad-spectrum–gram-negative bacilli, staphylococci–fluoroquinolone with ↓ activity against streptococci and anaerobes. See Fluoroquinolone.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
If your doctor chooses a fluoroquinolone drug (other drugs in this class besides Cipro include Avelox, Floxin, Levaquin, Maxaquin, Noroxin, Penetrex, Tequin, and Zagam) consider cutting back on the intensity of your training and be sure to monitor and report any orthopedic pain to your doctor.
These include ciprofloxacin (Cipro), enoxacin (Penetrex), gatifloxacin (Tequin), levofloxacin (Levaquin), lomefloxacin (Maxaquin), moxifloxacin (Avelox), norfloxacin (Noroxin), ofloxacin (Floxin), and sparfloxacin (Zagam).
These include ciprofloxacin (Cipro), enoxacin (Penetrex), gatifloxacin (Tequin), 1evofloxacin (Levaquin), lomefloxacin (Maxaquin), moxifloxacin (Avelox), norfloxacin (Noroxin), ofloxacin (Floxin), and sparfioxacin (Zagam).
for skin ailments), Eulexin (from Schering-Plough for prostate cancer), Nimotop (from Bayer Pharmaceutical Division for stroke), Penetrex (from Rhone-Polene Rorer Pharmaceuticals Inc.
The others are Eulexin, Nimotop, Relafen, Dermatop, Penetrex, and Cardiogen-82.
The other potential candidates for patent extensions are ScheringPlough's cancer drug Eulexin; Bayer Corp.'s calcium channel blocker Nimotop; SmithKline Beecham PLC's nonsteroidal anti-inflammatory medication (NSAID) Relafen; Dermatop, Ortho Dermatological's corticosteroid emollient cream; RhonePouleneu Rorer Pharmaceuticals Inc.'s antibacterial drug Penetrex; Braccol Diagnostics' diagnostic agent Cardiogen-82; and G.D.
from Hoechst Marion Roussel Inc.; Penetrex, of Rhone-Poulenc Rorer Inc.; and Nimotop, made by Bayer AG.
Among the drugs approved in the closing weeks of the year were several antibiotics: Lorabid, made by Eli Lilly & Co.; Penetrex, by Warner-Lambert Co.; and Cefzil, by Bristol-Myers Squibb Co.